<?xml version="1.0" encoding="UTF-8"?>
<p>Trial of Treatments for COVID
 <italic>-</italic>19 in Hospitalized Adults (DisCoVeRy) study will be conducted in Europe by the National Institutes of Health
 <xref ref-type="fn" rid="fn0001">
  <sup>1</sup>
 </xref> and Medical Research in France (Inserm), and it will include the same therapeutic molecules and a total of 3,200 patients from Belgium, Germany, Luxembourg, the Netherlands, Spain, Sweden, and the United Kingdom. Several medical centers will start collecting data as new cases emerge, and the first data analysis will be performed after 15 days of treatment (
 <xref rid="B70" ref-type="bibr">70</xref>).
</p>
